Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
US8236763B2 · kind B2 · utility
3Cited by
11References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 8, 2005 |
| Grant date | Aug 7, 2012 |
| Priority date | — |
| Expiry date | Jan 7, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of antagonists to the CB1 receptor for the preparation of a composition for the treatment of hepatic diseases and preferably to the use of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.